Albany Molecular Research, Inc. (NASDAQ:AMRI) Investor Lawsuit Alleges Misleading Statements

San Diego, CA -- (SBWIRE) -- 11/17/2014 -- An investor, who purchased shares of Albany Molecular Research, Inc. (NASDAQ:AMRI), filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Albany Molecular Research in connection with certain allegedly false and misleading statements made between August 5, 2014 and November 5, 2014.